Company Filing History:
6 out of 1,935 
4 out of 896 
2 out of 291 
Years Active: 2003-2020
Title: Shijie Song: Innovator in Granulocyte Colony-Stimulating Factor Research
Introduction
Shijie Song is a prominent inventor based in Tampa, FL (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of granulocyte colony-stimulating factor (G-CSF) receptors. With a total of 6 patents to his name, his work has the potential to impact the treatment of various neurodegenerative diseases.
Latest Patents
Shijie Song's latest patents focus on small molecules that mimic or antagonize the actions of granulocyte colony-stimulating factor (G-CSF). These patents describe compounds that can modulate the G-CSF receptor, acting as agonists, antagonists, or mixed/partial agonists/antagonists. The methods outlined in these patents include treating conditions such as neurodegenerative diseases by administering the described compounds.
Career Highlights
Throughout his career, Shijie Song has worked with notable institutions, including the University of South Florida and the United States Government as represented by the Department of Veterans Affairs. His research has contributed to advancements in understanding and treating conditions related to G-CSF.
Collaborations
Shijie Song has collaborated with esteemed colleagues, including Juan Sanchez-Ramos and Vasyl Sava. These partnerships have further enriched his research and innovation in the field.
Conclusion
Shijie Song is a dedicated inventor whose work in G-CSF research holds promise for future medical advancements. His contributions continue to pave the way for innovative treatments in neurodegenerative diseases.